gp140, the C3d receptor of human B lymphocytes, is also the Epstein-Barr virus receptor.

Raymond Frade, Monique Barel, Barbro Ehlin‐Henriksson, +1

Proceedings of the National Academy of Sciences

AllergyAutoimmune DiseaseEbv BindingMedicineEpstein-barr Virus Receptor +13

Enhancement of human B cell proliferation by an antibody to the C3d receptor, the gp 140 molecule

Raymond Frade, Marie Claude Crevon, Monique Barel, +4

European Journal of Immunology

Inhibition of Tumorigenicity and Metastasis of Human Melanoma Cells by Anti-Cathepsin L Single Chain Variable Fragment

Nathalie Rousselet, Lisa Mills, Didier Jean, +3

Cancer Research

Procathepsin-L, a proteinase that cleaves human C3 (the third component of complement), confers high tumorigenic and metastatic properties to human melanoma cells.

Raymond Frade, Fernando Rodrigues‐Lima, Shiu‐Feng Huang, +3

PubMed

ImmunologyPathologyImmunologic MechanismDermatologyImmunotherapy +15

Isolation and characterization of a C3b receptor‐like molecule from membranes of a human B lymphoblastoid cell line (Raji)

Monique Barel, Christiane Charriaut, Raymond Frade

FEBS Letters

Proteinlipid InteractionMolecular ImmunologyC3b Receptor‐like MoleculeSignal TransductionNatural Sciences +9

gp140, a C3b‐binding membrane component of lymphocytes, is the B cell C3dg/C3d receptor (CR2) and is distinct from the neutrophil C3dg receptor (CR4)

Raymond Frade, Barry L. Myones, Monique Barel, +3

European Journal of Immunology

Identification of RB18A, a 205 kDa new p53 regulatory protein which shares antigenic and functional properties with p53

Pascal Drané, Monique Barel, Michelle Balbo, +1

Oncogene

Functional PropertiesNatural SciencesMolecular BiologyGene ExpressionMedicine +2

C3-cleaving membrane proteinase. A new complement regulatory protein of human melanoma cells.

Markus Ollert, Raymond Frade, A Fiandino, +6

The Journal of Immunology

Molecular RegulationImmunologyImmunoeditingCell DeathImmunologic Mechanism +20

Monoclonal and anti-idiotypic anti-EBV/C3d receptor antibodies detect two binding sites, one for EBV and one for C3d on glycoprotein 140, the EBV/C3dR, expressed on human B lymphocytes.

Monique Barel, A Fiandino, Alain Delcayre, +2

The Journal of Immunology

Glycoprotein 140Immunocytochemical TechniqueImmunologyImmunodominanceHuman B +16

Activation of human platelets through gp140, the C3d/EBV receptor (CR2)

Danièle Nunez, Christiane Charriaut‐Marlangue, Monique Barel, +2

European Journal of Immunology